KidneyCAN | Advocacy Groups

An expert explains what patients need to keep in mind and what conversations they should be having with their care teams.

Even with the increase of immunotherapy utilization to treat patients with advanced renal cell carcinoma, more research is needed to determine in which order to administer it as later lines of therapy.

Therapies that target specific characteristics on kidney cancer cells are showing promise in the space, an expert explained.

With new treatments being explored, it’s an exciting time for patients with kidney cancer, an expert explained.

An expert explained what aspects of a patient’s disease cancer care teams use to determine the best treatment options for patients with clear cell renal cell carcinoma.

Patients with BAP1-mutated renal cell carcinoma who were treated with Lynparza obtained responses with favorable side effect profiles.

An expert gives an overview of up-and-coming treatments for patients with kidney cancer.

Long-term follow-up data showed that Lenvima plus Keytruda continued to show benefit in patients with metastatic kidney cancer.

Immunotherapy combinations tended to improve outcomes for patients with metastatic kidney cancer who go on to receive surgery.

Radiation is an emerging treatment modality in kidney cancer. Research shows that it is effective and helps patients maintain a good quality of life.

Keytruda after nephrectomy improved disease-free survival rates in patients with clear cell renal cell carcinoma regardless of disease risk or stage.

Responses to treatment with Lenvima plus Keytruda for advanced renal cell carcinoma were present regardless of PD-L1 status.

Patients with Medicaid or no insurance may have worse survival outcomes compared with Medicare or private insurance in those with metastatic renal cell carcinoma.

As a part of its “Speaking Out” video series, CURE® spoke with Meryl Uranga, on behalf of KidneyCAN, about the importance of working as a team with their clinicians and getting educated before making decisions.

In a recent interview with Cancer Horizons®, the medical liaison for KidneyCAN, discussed the basics of kidney cancer and what she thinks patients should know.

As a part of its Speaking Out video series, on behalf of KidneyCAN, CURE® spoke with Meryl Uranga, a patient advocate, about integrative care for kidney cancer.

As a part of its Speaking Out video series, on behalf of KidneyCAN, CURE® spoke with Meryl Uranga, a patient advocate, about the side effects associated with kidney cancer treatment.

As a part of its Speaking Out video series, on behalf of KidneyCAN, CURE® spoke with Meryl Uranga about the importance of patients being their own advocate when communicating with their physician.

As a part of its Speaking Out video series, on behalf of KidneyCAN, CURE® spoke with Meryl Uranga about the importance of patients being their own advocate when communicating with their physician.

For this month’s Community Spotlight, KidneyCAN spoke to David Roy and Josie Garcia-Roy, both California natives living and working in the Los Angeles area.

KidneyCAN held a Town Hall in January to discuss the latest research in kidney cancer with leading experts.

In our December newsletter, we announced patient education Town Hall events, re-capped 2021 legislative advocacy, highlighted a young couple dealing with kidney cancer in our Community Spotlight, and shared the latest kidney cancer research news.

KidneyCAN is partnering with several organizations to rally delegates from all over the United States to advocate for federal funding for kidney cancer research.

On October 7-8, 2021, KidneyCAN hosted the third annual Kidney Cancer Research Summit in Philadelphia, Pennsylvania.

In our October newsletter, we announced a “Handling the Holidays with Cancer” Town Hall event, re-capped KCRS21, highlighted a very special father-daughter duo in our Community Spotlight, and shared the latest kidney cancer research news.

KidneyCan hosts a YouTube channel where research news, patient education, and legislative advocacy videos keep our community connected to the latest developments.

In this feature, Tony and Jackie share how they stay positive and help others in the kidney cancer community.